Brain-medicine creator Alkermes plans to buy narcolepsy treatment-maker Avadel
MLex Summary: Pharmaceutical company Alkermes plans to pay approximately $2.1 billion to acquire sleep disorder treatment-maker Avadel Pharmaceuticals. Both companies are traded on NASDAQ.See attached document. ...To view the full article, register now.
Already a subscriber? Click here to view full article